Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06100276
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-10-20
Brief Title:
Safety Tolerability and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis SOD1-ALS
Sponsor:
UniQure Biopharma BV
Organization:
UniQure Biopharma BV
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-20
First Submit QC Date:
October 20 2023
Study First Post Date:
2023-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL